Monica Ahluwalia, MD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Cardiovascular Medicine

MD, Robert Wood Johnson Medical School
BS, Rutgers University



Monica Ahluwalia MD, FACC received her MD at Robert Wood Johnson Medical School with Distinction in Research, and completed her Internal Medicine Residency, Cardiovascular Medicine Fellowship and Advanced Heart Failure & Transplant Cardiology Fellowship at University of Pennsylvania, NYU School of Medicine and Brigham and Women’s Hospital, respectively, where she received the Baughman Award of Clinical Excellence. Dr. Ahluwalia is currently an Assistant Professor of Cardiovascular Medicine at the Chobanian and Avedisian School of Medicine and Staff Cardiologist at the Boston Medical Center Boston, MA where she is medical director of the Inherited Cardiovascular Diseases Program. She is also an Advanced Heart Failure & Transplant Cardiologist at Brigham and Women’s Hospital in Boston, MA. Her current research interests include studying the use of machine learning to detect hypertrophic cardiomyopathy and develop enhanced risk stratification tools among diverse populations in collaboration with data scientists to help mitigate healthcare disparities. Outside the University, she is a member of societies including American College of Cardiology, American Heart Association and Heart Failure Society of America.

Diversity, Equity, Inclusion and Accessibility

As a daughter of immigrant parents in the United States, I have personally witnessed challenges that minorities encounter in our community. During my residency and fellowship training, I had the opportunity to directly care for patients from both inner-city population, underrepresented minorities, as well as men and women of different gender and sexual orientations. I have also been dedicated to the recruitment and mentorship of diverse faculty and medical staff, provide a welcoming environment robust with kindness and empathy for both patients and colleague and cultivate an appealing environment for people for different cultural backgrounds to work together.

More recently, as medical director of the Inherited Cardiomyopathy Program at Boston Medical Center, the largest safety net hospital in New England where I serve an underrepresented minority population, my current research aims to bridge gaps in access to healthcare. Recent studies have identified a need for a clinical care model that provides comprehensive care for patients and their families. More specifically, Black and other racial/ethnic minority patients with inherited cardiomyopathies are underrepresented in cardiovascular genetics clinics, experience inequities in care with less access to genetic testing and septal reduction therapies, and overall, have a higher burden of disease in part due to underdiagnosis and delayed diagnosis. In collaboration with data scientists, I am currently working on building machine learning algorithms to help improve detection of hypertrophic cardiomyopathy with a goal to implement in a community-based setting. This would help improve timely diagnosis and early referral for medical, device and surgical therapies. I am also examining genetic risk and clinical outcomes in a larger, more diverse cohort of patients with hypertrophic cardiomyopathy. Understanding genetic risk will provide better insight into underlying disease pathophysiology, which may help identify patients with early onset disease and develop new tools to assess risk stratification. Further, this information would direct new areas of investigation, including developing therapeutics for more precision-based medicine in a largely underrepresented population.

In conclusion, I firmly believe that our education should strive to uphold diversity and encourage a more inclusive approach for people of all genders, races, ethnicities, and socioeconomic backgrounds with a wider mission to eliminate healthcare disparities by treating all patients with compassion and dignity. With the help of academic medicine, I will continue to educate others to embrace such endeavors that help, protect and support communities everywhere.



CV027031: A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
02/06/2024 - 02/06/2029 (PI)
Bristol-Myers Squibb Company


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Ahluwalia M, Liu J, Olivotto I, Parikh V, Ashley EA, Michels M, Ingles J, Lampert R, Stendahl JC, Colan SD, Abrams D, Pereira AC, Rossano JW, Ryan TD, Owens AT, Ware JS, Saberi S, Helms AS, Day S, Claggett B, Ho CY, Lakdawala NK. The Clinical Trajectory of NYHA Functional Class I Patients With Obstructive Hypertrophic Cardiomyopathy. JACC Heart Fail. 2025 Feb; 13(2):332-343. PMID: 39520446
     
  2. Almadani A, Sarwar A, Agu E, Ahluwalia M, Kpodonu J. HCM-Echo-VAR-Ensemble: Deep Ensemble Fusion to Detect Hypertrophic Cardiomyopathy in Echocardiograms. IEEE Open J Eng Med Biol. 2025; 6:193-201. PMID: 39698121; PMCID: PMC11655110; DOI: 10.1109/OJEMB.2024.3486541;
     
  3. Ahluwalia M, Kpodonu J, Agu E. Risk Stratification in Hypertrophic Cardiomyopathy: Leveraging Artificial Intelligence to Provide Guidance in the Future. JACC Adv. 2023 Sep; 2(7):100562. PMID: 38939491; PMCID: PMC11198167; DOI: 10.1016/j.jacadv.2023.100562;
     
  4. Sehgal S, Subramanyam P, Ahluwalia M, Rastogi A, Bergman G. Transcatheter mitral valve implantation: Implications of interventional technique and 3D echocardiography for complex valve-in-valve paravalvular leak. Ann Card Anaesth. 2023; 26(2):227-231. PMID: 37706394; PMCID: PMC10284472; DOI: 10.4103/aca.aca_166_21;
     
  5. Ahluwalia M, Onwuanyi A, Agu E, Kpodonu J. Advocating for a Path to Increase Diversity in Enrollment in Cardiovascular Clinical Trials. JACC Adv. 2022 Dec; 1(5):100152. PMID: 38939463; PMCID: PMC11198180; DOI: 10.1016/j.jacadv.2022.100152;
     
  6. Ahluwalia M, Ho CY. Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy. Heart. 2021 02; 107(3):183-189. PMID: 33172912; DOI: 10.1136/heartjnl-2020-316798;
     
  7. Ahluwalia M, Givertz MM, Mehra MR. A proposed strategy for management of immunosuppression in heart transplant patients with COVID-19. Clin Transplant. 2020 11; 34(11):e14032. PMID: 32621523; PMCID: PMC7361140; DOI: 10.1111/ctr.14032;
     
  8. Vani A, Ahluwalia M, Donnino R, Jung A, Vaynblat M, Latson L, Saric M. A case of nonvalvular endocarditis with biventricular apical infected thrombi. Echocardiography. 2020 07; 37(7):1072-1076. PMID: 32654168
     
  9. Almufleh A, Ahluwalia M, Givertz MM, Weintraub J, Young M, Cooper I, Shea EL, Mehra MR, Desai AS. Short-term Outcomes in Ambulatory Heart Failure during the COVID-19 Pandemic: Insights from Pulmonary Artery Pressure Monitoring. J Card Fail. 2020 07; 26(7):633-634. PMID: 32505815; PMCID: PMC7271870; DOI: 10.1016/j.cardfail.2020.05.021;
     
  10. Ahluwalia M, Givertz MM, Mehra MR. Bariatric surgery and heart transplantation outcomes: A note of caution. J Heart Lung Transplant. 2020 09; 39(9):986-987. PMID: 32307249; DOI: 10.1016/j.healun.2020.03.011;
     
Showing 10 of 22 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 22 publications over 10 distinct years, with a maximum of 7 publications in 2020

YearPublications
20131
20151
20161
20171
20183
20193
20207
20221
20232
20242

Contact for Mentoring:

72 E. Concord Street
Boston MA 02118
Google Map


Ahluwalia's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Similar People
_
Same Department